Mylan Wins PTAB Review Of Pfizer's Toviaz Patents
The Patent Trial and Appeal Board has agreed to hear challenges by Mylan Pharmaceuticals Inc. to four patents owned by UCB Pharma GmbH relating to Pfizer Inc.'s Toviaz overactive bladder treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article